Interventions for Old World cutaneous leishmaniasis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD005067.pub4PMID 29149474PMCID PMC6486265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interventions for Old World cutaneous leishmaniasis.

  2017cited by this paper
• Intralesional Versus Oral Chloroquine in Cutaneous Leishmaniasis: Comparison of Outcome, Duration of Treatment and Total Dose of Drug.

  2016cited by this paper
• A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions

  2016cited by this paper
• Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

  2016cited by this paper
• Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis

  2016cited by this paper
• Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial

  2016cited by this paper
• Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial

  2016cited by this paper
• Diagnosis of cutaneous leishmaniasis: why punch when you can scrape?

  2015cited by this paper
• Interventions for hidradenitis suppurativa.

  2015cited by this paper
• A comparative study between the efficacy of oral cimetidine and low‐dose systemic meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment of cutaneous leishmaniasis

  2015cited by this paper
• The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride (Thio‐Ben) along with cryotherapy: a single‐blind randomized clinical trial

  2015cited by this paper
• Randomized, double‐blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis

  2015cited by this paper
• Comparison of Lesion Improvement in Lupoid Leishmaniasis Patients with Two Treatment Approaches

  2015cited by this paper
• Vector and reservoir control for preventing leishmaniasis

  2015cited by this paper
• Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management

  2015cited by this paper
• Interventions for rosacea.

  2015cited by this paper
• Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial

  2015cited by this paper
• Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations.

  2015cited by this paper
• LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.

  2014cited by this paper
• Rapid Healing of Cutaneous Leishmaniasis by High-Frequency Electrocauterization and Hydrogel Wound Care with or without DAC N-055: A Randomized Controlled Phase IIa Trial in Kabul

  2014cited by this paper
• Leishmaniasis in immunosuppressed individuals.

  2014cited by this paper
• A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan

  2014cited by this paper
• Leishmaniasis.

  2014cited by this paper
• The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major

  2014cited by this paper
• Global database of leishmaniasis occurrence locations, 1960–2012

  2014cited by this paper
• Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.

  2013cited by this paper
• Long‐term efficacy of single‐dose radiofrequency‐induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India

  2013cited by this paper
• Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis

  2013cited by this paper
• Old World cutaneous leishmaniasis: diagnosis and treatment.

  2013cited by this paper
• Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis

  2013cited by this paper
• Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial

  2013cited by this paper
• The efficacy of 5% trichloroacetic acid cream in the treatment of cutaneous leishmaniasis lesions

  2012cited by this paper
• Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.

  2012cited by this paper
• Is topical nitric oxide and cryotherapy more effective than cryotherapy in the treatment of old world cutaneous leishmaniasis?

  2012cited by this paper
• Topical treatment modalities for old world cutaneous leishmaniasis: a review.

  2012cited by this paper
• Comparison of Intralesional Two Percent Zinc Sulfate and Glucantime Injection in Treatment of Acute Cutaneous Leishmaniasis

  2012cited by this paper
• A double-blind, randomized, clinical trial on the antileishmanial activity of a Morinda citrifolia (Noni) stem extract and its major constituents.

  2012cited by this paper
• Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.

  2012cited by this paper
• Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial

  2012cited by this paper
• Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.

  2012cited by this paper
• Leishmaniasis Worldwide and Global Estimates of Its Incidence

  2012cited by this paper
• Liquid nitrogen cryotherapy on Leishmania donovani cutaneous leishmaniasis

  2011cited by this paper
• Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial.

  2011cited by this paper
• [Reactive oxygen species and oxidative stress].

  2011cited by this paper
• Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine

  2011cited by this paper
• Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica

  2011cited by this paper
• THE COMPARISON BETWEEN TRICHLOROACETIC ACID 50% AND CO2 LASER IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS SCAR

  2011cited by this paper
• Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.

  2011cited by this paper
• Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis

  2011cited by this paper
• Efficacy of CO2 laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate

  2011cited by this paper
• Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

  2011cited by this paper
• Leishmaniasis impact and treatment access.

  2011cited by this paper
• A Randomized Controlled Trial of Local Heat Therapy Versus Intravenous Sodium Stibogluconate for the Treatment of Cutaneous Leishmania major Infection

  2010cited by this paper
• Tropical medicine rounds: Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun

  2010cited by this paper
• Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.

  2010cited by this paper
• Efficacy of short‐duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous leishmaniasis in India

  2010cited by this paper
• CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials

  2010cited by this paper
• Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study

  2010cited by this paper
• Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis.

  2010cited by this paper
• Leishmaniasis recidivans among school children in Bam, South‐east Iran, 1994–2006

  2010cited by this paper
• Designing and reporting clinical trials on treatments for cutaneous leishmaniasis.

  2010cited by this paper
• Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani

  2010cited by this paper
• Avoidable Waste in the Production and Reporting of Research Evidence

  2009cited by this paper
• WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

  2009cited by this paper
• Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

  2009cited by this paper
• Interventions for American cutaneous and mucocutaneous leishmaniasis.

  2009cited by this paper
• Artesunate plus sulfamethoxypyrazine/pyrimethamine for the treatment of cutaneous leishmaniasis: a double-blind, placebo-controlled clinical trial.

  2009cited by this paper
• Dapsone 5% Gel

  2009cited by this paper
• Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials

  2009cited by this paper
• Interventions for alopecia areata.

  2008cited by this paper
• Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.

  2008cited by this paper
• Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis.

  2008cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• The Relationship between Leishmaniasis and AIDS: the Second 10 Years

  2008cited by this paper
• A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.

  2008cited by this paper
• The antischistosomal efficacies of artesunate–sulfamethoxypyrazine–pyrimethamine and artemether–lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria

  2008cited by this paper
• Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.

  2007cited by this paper
• Consensus panel recommendations for chronic and acute wound dressings.

  2007cited by this paper
• Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.

  2007cited by this paper
• Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate

  2007cited by this paper
• Leishmania major infection in a patient with visceral leishmaniasis: treatment with Amphotericin B

  2007cited by this paper
• First case of typical Old World cutaneous leishmaniasis treated with miltefosine

  2007cited by this paper
• Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials.

  2007cited by this paper
• Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.

  2007cited by this paper
• When are randomised trials unnecessary? Picking signal from noise

  2007cited by this paper
• It's only numbers

  2007cited by this paper
• Cutaneous leishmaniasis.

  2007cited by this paper
• Injectable paromomycin for Visceral leishmaniasis in India.

  2007cited by this paper
• Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.

  2007cited by this paper
• Artemisinins and synthetic trioxolanes in the treatment of helminth infections

  2007cited by this paper
• Cutaneous leishmaniasis treatment.

  2007cited by this paper
• Kinetoplastid Biology and Disease BioMed Central Review

  2007cited by this paper
• Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.

  2006cited by this paper
• Leishmania: risk to the blood supply

  2006cited by this paper
• A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis.

  2006cited by this paper
• Leishmaniasis and poverty.

  2006cited by this paper
• Comparative Effect of Topical Trichloroacetic Acid and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis

  2006cited by this paper
• Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis

  2006cited by this paper
• Current scenario of drug development for leishmaniasis.

  2006cited by this paper
• In‐vitro and in‐vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis

  2006cited by this paper

• Cutaneous Leishmaniasis Successfully Treated with Photodynamic Therapy: A Case Series.

  2026cites this paper
• Cutaneous leishmaniasis: epidemiology, treatment access and translational challenges of topical therapies

  2026cites this paper
• Beyond the Skin: Topical Amphotericin B Nanocarriers Targeting Cutaneous Leishmaniasis with Suppression of Lymphatic Parasite Burden

  2026cites this paper
• Leishmaniasis

  2025cites this paper
• Dual drug co-encapsulation into liposomes and liposome-derived nanosystems for improved synergistic treatment of skin diseases

  2025cites this paper
• Therapeutic potential of iron oxide nanoparticles for cutaneous leishmaniasis: a systematic review of in vitro and in vivo studies

  2025cites this paper
• Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations

  2025cites this paper
• Structural Drivers of Cutaneous Leishmaniasis: Examining How the Converging Effects of Displacement, Environmental Disruption, and Political Instability Reshape Epidemiology Beyond Endemic Regions

  2025cites this paper
• Unveiling risk factors and sandfly ecology in cutaneous leishmaniasis-endemic areas of the Asir Region, Saudi Arabia.

  2025cites this paper
• Epidemiological aspects of cutaneous leishmaniasis in Southeastern Iran from 2019 to 2023

  2025cites this paper
• The burden of cutaneous leishmaniasis in Libya (2019–2022): Epidemiological insights and treatment practices

  2025cites this paper
• Cutaneous leishmaniasis in Afghanistan

  2025cites this paper
• Cutaneous and Mucocutaneous Leishmaniasis: Perspectives on Immunity, Virulence, and Treatment

  2025cites this paper
• Nanofibrous patches for targeted therapy of cutaneous leishmaniasis caused by Leishmania major: a preclinical amphotericin B platform

  2025cites this paper
• Demographic characteristics and clinical features of patients presenting with different forms of cutaneous leishmaniasis, in Lay Gayint, Northern Ethiopia

  2024cites this paper
• Complicated Mucocutaneous Leishmaniasis With Superimposed Cellulitis in an Immunocompromised Patient: A Case Report

  2024cites this paper
• Development of a Core Outcome Measure Instrument; "LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis

  2024cites this paper
• The impact of continuity correction methods in Cochrane reviews with single‐zero trials with rare events: A meta‐epidemiological study

  2024cites this paper
• A Review of the Dermatologic Clinical Applications of Topical Photodynamic Therapy

  2024cites this paper
• Activity of Argemone Ochroleuca Extract On the in Vitro Viability of Cutaneous Leishmaniasis Promastigotes Comparison to Sodium Stibogluconate Drug

  2023cites this paper
• Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: A systematic review and meta-analysis

  2023cites this paper
• Complicated Cutaneous Leishmaniasis in a Patient under Combined Immunosuppression.

  2023cites this paper
• Protocol for a prospective observational cohort study of cutaneous leishmaniasis in Ethiopia

  2023cites this paper
• The Quest for Understanding Cutaneous Leishmaniasis in Northern Province, Sri Lanka: An Analysis of Clinical Data From the District General Hospital, Vavuniya

  2023cites this paper
• Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review

  2023cites this paper
• Which trial do we need? A collaborative platform trial for cutaneous leishmaniasis amongst international travellers.

  2023cites this paper
• Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host

  2023cites this paper
• A non-healing ulcerating lip lesion.

  2023cites this paper
• Multiple Ulcerated Nodules.

  2023cites this paper
• Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial

  2022cites this paper
• Comparing the Efficacy of Monotherapy with Intralesional Meglumine Antimoniate and Combination Therapy with Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate for the Treatment of Acute Cutaneous Leishmaniasis

  2022cites this paper
• Biophysical and ultrasonographic changes of acute Old World cutaneous leishmaniasis skin lesions in comparison with uninvolved skin: A possible tool for non‐invasive early detection and treatment outcome assessment

  2022influential citation
• Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis

  2022cites this paper
• A case of a verrucous and pseudotumoral mass on the leg that resolved with cryotherapy

  2022cites this paper
• Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.

  2022influential citation
• Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments

  2022cites this paper
• Leishmania mexicana promotes pain-reducing metabolomic reprogramming in cutaneous lesions

  2022influential citation
• Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews

  2022cites this paper
• Phototherapy and Optical Waveguides for the Treatment of Infection.

  2021cites this paper
• Transfersomes as alternative topical nanodosage forms for the treatment of skin disorders.

  2021cites this paper
• Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

  2021cites this paper
• The First Record of Zoonotic Genes of Cutaneous Leishmaniasis among Human, Dogs, and Sandflies by Nested Polymerase Chain Reaction and Phylogenetic Analyses

  2021influential citation
• Cutaneous and Mucocutaneous Leishmaniasis.

  2021cites this paper
• Morphological alterations of Thymus during the early murine leishmaniasis.

  2021cites this paper
• Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design

  2021cites this paper
• In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy

  2021cites this paper
• Fractional CO2 laser-assisted topical rifamycin drug delivery in the treatment of pediatric cutaneous leishmaniasis.

  2021cites this paper
• An epidemiological study of cutaneous leishmaniosis in human and dogs

  2021cites this paper
• The Sporadic cutaneous leishmaniasis due to Leishmania infantum in Morocco: A presumably trend towards endemicity.

  2021cites this paper
• A Promising Cutaneous Leishmaniasis Treatment with a Nanoemulsion-Based Cream with a Generic Pentavalent Antimony (Ulamina) as the Active Ingredient

  2021influential citation
• Antileishmanial Drug Discovery and Development: Time to Reset the Model?

  2021cites this paper
• Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review

  2021cites this paper
• Cutaneous and Mucocutaneous Leishmaniasis.

  2021cites this paper
• Cutaneous leishmaniasis in refugees from Syria: complex cases in Berlin 2015-2020.

  2020cites this paper
• Cutaneous leishmaniasis: A great imitator.

  2020cites this paper
• Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study

  2020cites this paper
• Evidence supporting the enhanced efficacy of pentavalent antimonials with adjuvant therapy for cutaneous leishmaniasis: a systematic review and meta‐analysis

  2020cites this paper
• Local therapy in cutaneous leishmaniasis: a review study

  2020cites this paper
• The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years

  2020cites this paper
• Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study

  2020cites this paper
• Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients

  2020cites this paper
• Effective Treatment of Cutaneous Leishmaniasis with Photodynamic Therapy of Methylene Blue: A Case Report

  2020cites this paper
• Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.

  2020cites this paper
• Clinical and Epidemiological study of Cutaneous Leishmaniasis from two tertiary care hospitals of Jammu and Kashmir: an Emerging Disease in North India.

  2020cites this paper
• Essential Oil from Melaleuca leucadendra: Antimicrobial, Antikinetoplastid, Antiproliferative and Cytotoxic Assessment

  2020cites this paper
• An overview of the treatment of cutaneous leishmaniasis

  2020cites this paper
• Leishmaniasis

  2020cites this paper
• Allergic contact dermatitis caused by paromomycin

  2019cites this paper
• Old world cutaneous leishmaniasis in Iran: clinical variants and treatments

  2019cites this paper
• Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis

  2019cites this paper
• The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial.

  2019cites this paper
• European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses

  2019cites this paper
• Comparison of Intralesional Meglumine Antimonite along with oral Itraconazole to Intralesional Meglumine Antimonite in the treatment of Cutaneous Leishmaniasis

  2019cites this paper
• Efficacy of erbium glass laser in the treatment of Old World cutaneous leishmaniasis: A case series

  2019cites this paper
• Cutaneous Leishmaniasis: Updates in Diagnosis and Management.

  2019cites this paper
• Glucose‐6‐phosphate dehydrogenase (G6PD) activity can modulate macrophage response to Leishmania major infection

  2019cites this paper
• Comparison of efficacy of intralesional meglumine antimoniate vs. combination of 50% trichloroacetic acid and intralesional meglumine antimoniate in patients of cutaneous leishmaniasis

  2019cites this paper
• Epidemiological Study and Spatial Modeling of Cutaneous Leishmaniasis in Bushehr Province Using the Geographic Information System (GIS) from 2011 to 2015

  2019cites this paper
• Failure of an Innovative Low-Cost, Noninvasive Thermotherapy Device for Treating Cutaneous Leishmaniasis Caused by Leishmania tropica in Pakistan

  2019cites this paper
• Fractional Ablative CO2 Laser Followed by Topical Application of Sodium Stibogluconate for Treatment of Active Cutaneous Leishmaniasis: A Randomized Controlled Trial.

  2019influential citation
• Sand fly saliva: toward a vaccine against leishmaniases

  2019cites this paper
• Leishmaniasis cutánea, a propósito de un caso.

  2019cites this paper
• Effective treatment with photodynamic therapy of cutaneous leishmaniasis: A case report

  2019cites this paper
• Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis

  2019cites this paper
• RRTM_A_200218 11..18

  2019cites this paper
• Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis

  2018cites this paper
• Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan

  2018cites this paper
• Poster Presentations

  2018cites this paper
• Efficacy of the Imiqualine analog EAPB0503 against Cutaneous Leishmaniasis : A promising new treatment paradigm

  2018cites this paper
• Interventions to treat cutaneous leishmaniasis in children: A systematic review

  2018cites this paper
• Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review

  2018cites this paper
• EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica

  2018cites this paper
• It is on my skin, on my soul, and on my life : development of a disease-specific quality of life instrument for adult patients with acute cutaneous leishmaniasis in Iran

  2018influential citation
• Lived Experiences of Patients Suffering from Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study from Iran

  2018influential citation
• Leishmania tropica successfully treated with photodynamic therapy

  2018cites this paper
• An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol

  2018cites this paper
• Nodular Lymphangitis (Sporotrichoid Lymphocutaneous Infections). Clues to Differential Diagnosis

  2018cites this paper
• Comparison between the Efficacy and Safety of Intralesional Sodium Stibogluconate Solution and Intralesional Metronidazole Solution in the Treatment of Cutaneous Leishmaniasis

  2018cites this paper
• Leishmaniasis.

  2018cites this paper
• Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991–2015

  2018cites this paper